REGN favors upside as long as it stays above price trendline as the part of iii started from October-2023 low and expect few more highs before pullback in iv correction.
Reasons for bullish bias:
- Simple DOW theory
- Entry at HH breakout
- No divergence
Here are the recommended trading levels:
Entry Level(CMP): 1000.64
Stop Loss Level: 949.00
Take Profit Level 1: 1052.28
Take Profit Level 2: 1103.92
Take Profit Level 3: Open
Down channel and following up channel
I expect a bullish breakout from the current up channel a continuation from the last move up
This expectation is shown with the bars pattern indicator
Daily timeframe
Looking at the REGN Regeneron Pharmaceuticals options chain ahead of earnings , I would buy the $730 strike price Puts with
2023-2-17 expiration date for about
$16.53 premium.
If the options turn out to be profitable Before the earnings release, I would sell at least 50%.
Looking forward to read your opinion about it.
I am buying $REGN again here.
I like the base, the volume signatures are great and it is showing great strength.
The industry is Biotech (and it is in top 30 industries currently in the stock market)
The IBD RS rating is 95
Fund ownership is increasing:
- notable funds owning it are: American Century Focused Dynam, JP Morgan, FIdelity Contrafun, MFS Frowth,...
First instance the three waves led to the point I have labelled as the loading emoji
Second instance three waves were seen aswell, which also led to a point like this
Bull runs follow these loading emoji points
Is Regeneron Pharmaceuticals ready for a new all-time high, or will it test again the previous one at $620 from October 2020 and confirm it as a strong resistance?
Regeneron Pharmaceuticals is a leading-edge biotech and pharmaceutical company that focuses on cytokines and tyrosine kinase receptors at the cellular level. First, Regeneron developed an experimental...
I'd enter Regeneron here at 580$ / share .
Risking 28$ in my position .
SL set at 552.
Price Targets are listed on chart : Previous ATH (664) , 800$ .
R:R is in our great favor as price can go $200 to the upside while only risking $28 per share.
Enter at own risk but I believe this is a great play.
NASDAQ:BNTX is in a strong uptrend, and last week tested its 50 day MA and its bouncing really good. Today is in focus as the price broke out a continuation pattern with good volume. Also, the MACD is close to make a buy signal with a bullish crossover.
BioNTech has a IBD relative strength rating of 97 and is Rank #2 in its industry, just behind NASDAQ:REGN ...
📌 REGN pipeline (with particular focus on the early stages) CEMIPLIMAB, REGN3767, REGN1979, REGN4018, REGN5458, REGN5459, REGN5678, REGN5093, REGN5713-5714-5715 and REGN-COV2 all have a lot of potential with particular focus around oncology.
As can be see with GILD, the covid positioning has already moved on a lot: we are ready to play chapter II and REGN...
Hello Everyone, I hope you'll Appreciate our Advanced Analysis on Price Action !
Check the Link on BIO and If you LIKE this analysis, Please support our page by hitting the LIKE👍 button
Feel free to request any pair/instrument analysis or ask any questions in the comment section below.
Strategy : Fibo retracement on bearish channel
Have a Good Take Profits ! ! !
REGN has been beaten down while the market is up. I think the bottom is near. Trendline is holding. Potentially starting wave 5
First PT: $550
SL: $470
